Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2024 09:20 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
July 09, 2024 07:57 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 3rd Annual Kidney Conference to be Held Virtually on July 15, 2024

ZyVersa welcomes one-on-one meetings at the HCW Kidney Conference on July 15, 2024.
September 08, 2022 09:15 ET | Source: Incannex Healthcare

Incannex to Participate in the Prestigious H.C. Wainwright 24th Annual Global Investment Conference

MELBOURNE, Australia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal...
September 07, 2022 16:05 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines to Present at H.C. Wainwright 24th Annual Global Investment Conference

BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
September 06, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022

SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
September 01, 2022 07:30 ET | Source: Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

HOUSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
May 10, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at Upcoming Investor Conferences in May

SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on its proprietary tRNA...
January 04, 2022 08:03 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
January 03, 2022 07:00 ET | Source: ObsEva SA

ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference

GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
January 03, 2022 01:00 ET | Source: ObsEva SA

ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference

GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...

	
		OSZAR »